Susquehanna International Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.4K | Buy |
|
|||||
|
2025
Q1 | $91.3K | Sell |
|
|||||
|
2024
Q4 | $237K | Buy |
|
|||||
|
2024
Q3 | $113K | Buy |
|
|||||
|
2024
Q2 | $119K | Hold |
|
|||||
|
2024
Q1 | $185K | Hold |
|
|||||
|
2023
Q4 | $141K | Sell |
|
|||||
|
2023
Q3 | $303K | Sell |
|
|||||
|
2023
Q2 | $310K | Buy |
|
|||||
|
2023
Q1 | $55.5K | Buy |
|
|||||
|
2022
Q4 | $2.47K | Sell |
|
|||||
|
2022
Q3 | $6K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $46K | Buy |
|
|||||
|
2021
Q3 | $20K | Sell |
|
|||||
|
2021
Q2 | $167K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $54K | Buy |
|
|||||
|
2020
Q3 | $45K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $193K | Buy |
|